S. Pleschka

发表

Inhibition of Cytosolic Phospholipase A2α Impairs an Early Step of Coronavirus Replication in Cell Culture

B. Neuman, Christin Müller, M. Hardt, 2017, Journal of Virology.

Membrane Accumulation of Influenza A Virus Hemagglutinin Triggers Nuclear Export of the Viral Genome via Protein Kinase Cα-mediated Activation of ERK Signaling*

H. Klenk, S. Pleschka, R. Wagner, 2006, Journal of Biological Chemistry.

Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

Thorsten Wolff, Ulf R. Rapp, Stephan Ludwig, 2001, Nature Cell Biology.

Influenza Virus-induced AP-1-dependent Gene Expression Requires Activation of the JNK Signaling Pathway*

S. Pleschka, M. Kracht, U. Rapp, 2001, The Journal of Biological Chemistry.

MEK-Specific Inhibitor U0126 Blocks Spread of Borna Disease Virus in Cultured Cells

S. Pleschka, O. Planz, S. Ludwig, 2001, Journal of Virology.

Replication and Adaptive Mutations of Low Pathogenic Avian Influenza Viruses in Tracheal Organ Cultures of Different Avian Species

S. Pleschka, H. Petersen, S. Rautenschlein, 2012, PloS one.

Constitutive Activation of the Transcription Factor NF-κB Results in Impaired Borna Disease Virus Replication

S. Pleschka, T. Wolff, C. Ehrhardt, 2005, Journal of Virology.

Phosphoproteome Analysis of Cells Infected with Adapted and Nonadapted Influenza A Virus Reveals Novel Pro- and Antiviral Signaling Networks

U. Linne, K. Fritz-Wolf, K. Becker, 2019, Journal of Virology.

A fatal relationship--influenza virus interactions with the host cell.

S. Pleschka, T. Wolff, S. Ludwig, 1999, Viral immunology.

NF-κB-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas/FasL Is Crucial for Efficient Influenza Virus Propagation*

S. Pleschka, T. Wolff, F. Berberich-Siebelt, 2004, Journal of Biological Chemistry.

Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice

Stephan Ludwig, L. Stitz, S. Pleschka, 2004, Oncogene.

In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A Viruses

U. Dietrich, S. Pleschka, J. Ziebuhr, 2015, Scientific Reports.

Antiviral efficacy against Influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model.

Christin Müller, S. Pleschka, G. Müller, 2020, Antiviral research.

RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade

S. Pleschka, 2008, Biological chemistry.

Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway.

S. Pleschka, M. Kracht, U. Rapp, 2001, The Journal of biological chemistry.

NS Segment of a 1918 Influenza A Virus-Descendent Enhances Replication of H1N1pdm09 and Virus-Induced Cellular Immune Response in Mammalian and Avian Systems

M. Beer, S. Pleschka, Aravind Tallam, 2018, Front. Microbiol..

Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection.

J. Sznajder, W. Seeger, S. Pleschka, 2016, The Journal of clinical investigation.

Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury

S. Pleschka, T. Wolff, S. Ludwig, 2012, Journal of leukocyte biology.

Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia

W. Seeger, A. Gruber, S. Pleschka, 2013, PLoS pathogens.

Negative-strand RNA viruses: genetic engineering and applications.

S. Pleschka, A. García-Sastre, P. Palese, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Phylogenetic analysis of human influenza A/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains

S. Pleschka, J. Ziebuhr, E. M. Abdelwhab, 2016, Archives of Virology.

Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase

S. Pleschka, M. Stukova, M. Bergmann, 2017, Molecular therapy oncolytics.

Reassortment of NS Segments Modifies Highly Pathogenic Avian Influenza Virus Interaction with Avian Hosts and Host Cells

S. Pleschka, H. Petersen, S. Rautenschlein, 2013, Journal of Virology.

Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses

S. Pleschka, E. Domann, T. Hain, 2011, BMC complementary and alternative medicine.

Genetic incompatibilities and reduced transmission in chickens may limit the evolution of reassortants between H9N2 and panzootic H5N8 clade 2.3.4.4 avian influenza virus showing high virulence for mammals

Christin Müller, S. Pleschka, M. Ali, 2020, Virus evolution.

IRE1 Signaling As a Putative Therapeutic Target in Influenza Virus-induced Pneumonia.

W. Seeger, A. Günther, S. Pleschka, 2019, American journal of respiratory cell and molecular biology.

Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics

S. Pleschka, A. Mostafa, O. Ilinskaya, 2020, International journal of molecular sciences.

Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection

S. Pleschka, S. Ludwig, U. Rescher, 2020, Viruses.

The NS segment of H5N1 avian influenza viruses (AIV) enhances the virulence of an H7N1 AIV in chickens

S. Pleschka, F. Rodríguez, A. Chaves, 2014, Veterinary Research.

Conservation of coding potential and terminal sequences in four different isolates of Borna disease virus.

S. Pleschka, M. Schwemmle, P. Staeheli, 2001, The Journal of general virology.

The secRNome of Listeria monocytogenes Harbors Small Noncoding RNAs That Are Potent Inducers of Beta Interferon

F. Weber, Christin Müller, S. Pleschka, 2019, mBio.

Comparative kinase activity profiling of pathogenic influenza A viruses reveals new anti- and pro-viral protein kinases.

S. Pleschka, R. Schermuly, M. Schmitz, 2022, The Journal of general virology.

Time-Resolved Systems Medicine Reveals Viral Infection-Modulating Host Targets

Anders K. Haakonsson, Harald H. H. W. Schmidt, B. Blagoev, 2019, Systems medicine.

The Inﬂuenza A Virus Genotype Determines the Antiviral Function of NF- (cid:2) B

S. Pleschka, M. Schmitz, M. Kracht, 2016 .

Evolution of H5-Type Avian Influenza A Virus Towards Mammalian Tropism in Egypt, 2014 to 2015

R. Webby, S. Pleschka, Mahmoud M. Shehata, 2019, Pathogens.

Utilisation de substances actives destinees a la prophylaxie et/ou la therapie de maladies virales

S. Pleschka, H. Sedlacek, Oliver Planz, 2004 .

Use of substances that act as MEK inhibitor for the manufacture of a Arneimittels against DNA and RNA viruses

S. Pleschka, S. Ludwig, 2000 .

Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism

K. Büssow, S. Pleschka, W. Blankenfeldt, 2022, Nature Metabolism.

The Vesicular Stomatitis Virus Matrix Protein Inhibits Glycoprotein 130-Dependent STAT Activation1

S. Pleschka, P. Heinrich, S. Ludwig, 2001, The Journal of Immunology.

STAT Activation Protein Inhibits Glycoprotein 130-Dependent The Vesicular Stomatitis Virus Matrix

S. Pleschka, P. Heinrich, S. Ludwig, 2001 .

Differential Impact of Specific Amino Acid Residues on the Characteristics of Avian Influenza Viruses in Mammalian Systems

Christin Müller, S. Pleschka, M. Ali, 2022, Pathogens.

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF‐κB‐inhibiting activity

Thorsten Wolff, Stephan Ludwig, S. Pleschka, 2007, Cellular microbiology.

Borna disease virus: a unique pathogen and its interaction with intracellular signalling pathways

S. Pleschka, T. Wolff, O. Planz, 2009, Cellular microbiology.

influenza A virus . A plasmid-based reverse genetics system for

S. Pleschka, A. García-Sastre, P. Palese, 1996 .

Circulation of classical swine influenza virus in Europe between the wars?

M. Platzer, S. Pleschka, M. Groth, 2014, Archives of Virology.

Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3.

S. Pleschka, T. Wolff, C. Ehrhardt, 2004, FEBS letters.

Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand

Matthias Mack, Thomas Brunner, W. Seeger, 2008, The Journal of experimental medicine.

Alveolar Epithelial Cells Direct Monocyte Transepithelial Migration upon Influenza Virus Infection: Impact of Chemokines and Adhesion Molecules1

W. Seeger, S. Pleschka, M. Mack, 2006, The Journal of Immunology.

Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)

S. Pleschka, J. Hudson, Stephan Pleschka, 2009, Virology Journal.

PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems

Christin Müller, S. Pleschka, Mahmoud M. Shehata, 2020, Viruses.

Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV

S. Pleschka, Mahmoud M. Shehata, M. Ali, 2019, Vaccines.

Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.

S. Pleschka, O. Planz, S. Herold, 2011, Antiviral research.

Borna Disease Virus Nucleoprotein Interacts with the Cdc2-Cyclin B1 Complex

L. Stitz, S. Pleschka, F. Berberich-Siebelt, 2003, Journal of Virology.

Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells

Thorsten Wolff, Stephan Ludwig, S. Pleschka, 2006, Cellular microbiology.

Authorised medicinal product Aspecton® Oral Drops containing thyme extract KMTv24497 shows antiviral activity against viruses which cause respiratory infections

Christin Müller, S. Pleschka, A. Mostafa, 2018, Journal of Herbal Medicine.

Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview

S. Pleschka, T. Mettenleiter, A. Mostafa, 2018, Viruses.

Overview of influenza viruses.

S. Pleschka, 2013, Current topics in microbiology and immunology.

MEK inhibition impairs influenza B virus propagation without emergence of resistant variants

Thorsten Wolff, Stephan Ludwig, S. Pleschka, 2004, FEBS letters.

Influenza-virus-induced signaling cascades: targets for antiviral therapy?

S. Pleschka, T. Wolff, O. Planz, 2003, Trends in molecular medicine.

An inducible T7 RNA polymerase-dependent plasmid system for the expression of short hairpin RNAs

U. Tschulena, S. Pleschka, E. Flory, 2006, Molecular biotechnology.

The Influenza A Virus Genotype Determines the Antiviral Function of NF-κB

S. Pleschka, M. Schmitz, M. Kracht, 2016, Journal of Virology.

Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection

K. Schughart, R. Geffers, S. Pleschka, 2021, bioRxiv.

Signaling to Life and Death: Influenza Viruses and Intracellular Signal Transduction Cascades

S. Pleschka, T. Wolff, O. Planz, 2008 .

Bivalent role of the phosphatidylinositol‐3‐kinase (PI3K) during influenza virus infection and host cell defence

Thorsten Wolff, Stephan Ludwig, S. Pleschka, 2006, Cellular microbiology.

Anti-viral approaches against influenza viruses

S. Pleschka, T. Wolff, O. Planz, 2006, New Concepts of Antiviral Therapy.

HA-Membrane Accumulation Triggers RNP-Export 1 MEMBRANE ACCUMULATION OF INFLUENZA A VIRUS HEMAGGLUTININ TRIGGERS NUCLEAR EXPORT OF THE VIRAL GENOME VIA PKC α MEDIATED ACTIVATION OF ERK SIGNALING

H. Klenk, S. Pleschka, R. Wagner, 2006 .

Caspase 3 activation is essential for efficient influenza virus propagation

S. Pleschka, C. Ehrhardt, O. Planz, 2003, The EMBO journal.

Studies on reverse genetic systems for avian influenza virus and the Borna disease virus

S. Pleschka, 2003 .

CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.

U. Dietrich, F. Kirchhoff, S. Pleschka, 2011, European journal of pharmacology.

Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics

H. Klenk, S. Pleschka, T. Wolff, 2000, Journal of Virology.

Surface glycoprotein of influenza C virus: inactivation and restoration of the acetylesterase activity on nitrocellulose.

S. Pleschka, G. Herrler, G. Zimmer, 1993, Virus research.

Bacterial ribonuclease binase exerts an intra-cellular anti-viral mode of action targeting viral RNAs in influenza a virus-infected MDCK-II cells

Christin Müller, S. Pleschka, A. Mostafa, 2018, Virology Journal.

A Novel Antiviral Strategy against MERS-CoV and HCoV-229E Using Binase to Target Viral Genome Replication

Christin Müller, S. Pleschka, O. Ilinskaya, 2016, BioNanoScience.

Rac1 and PAK1 are upstream of IKK‐ε and TBK‐1 in the viral activation of interferon regulatory factor‐3

S. Pleschka, T. Wolff, C. Ehrhardt, 2004 .

Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade

R. Webster, S. Pleschka, J. Franks, 2007, Virology Journal.

Borna Disease Virus Nucleoprotein Interacts with the Cdc 2-Cyclin B 1 Complex

L. Stitz, S. Pleschka, F. Berberich-Siebelt, 2003 .

Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses

S. Finke, Christin Müller, S. Pleschka, 2023, PLoS pathogens.

Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR

Andreas Herrmann, Fabian Jolmes, Thorsten Wolff, 2017, Journal of Virology.

Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses

Christin Müller, Christin Müller, S. Pleschka, 2017, Antiviral Research.

MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases

S. Pleschka, O. Planz, S. Ludwig, 2023, Current Opinion in Virology.

The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo.

Christin Müller, S. Pleschka, C. Ehrhardt, 2017, Antiviral research.

Phylogenetic analysis of human influenza A/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains

S. Pleschka, J. Ziebuhr, A. Mostafa, 2016, Archives of Virology.

A plasmid-based reverse genetics system for influenza A virus

S. Pleschka, A. García-Sastre, P. Palese, 1996, Journal of virology.

The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors

Thorsten Wolff, Stephan Ludwig, S. Pleschka, 2002, Journal of Virology.

Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways

K. Schughart, S. Pleschka, T. Stiewe, 2020, The Journal of Biological Chemistry.

Influenza Virus-Induced Caspase-Dependent Enlargement of Nuclear Pores Promotes Nuclear Export of Viral Ribonucleoprotein Complexes

Christin Müller, M. Hardt, S. Pleschka, 2015, Journal of Virology.

Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.

Stephan Ludwig, S. Pleschka, O. Planz, 2011, Antiviral research.

Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients

T. Welte, S. Pleschka, O. Planz, 2018, Emerging Microbes & Infections.

Influenza A Virus NS1 Protein Activates the PI3K/Akt Pathway To Mediate Antiapoptotic Signaling Responses

Johannes G. Bode, Thorsten Wolff, Stephan Ludwig, 2007, Journal of Virology.

Ancestral sequence reconstruction pinpoints adaptations that enable avian influenza virus transmission in pigs

Gavin J. D. Smith, R. Webster, R. Webby, 2021, Nature Microbiology.

Activation of c-jun N-Terminal Kinase upon Influenza A Virus (IAV) Infection Is Independent of Pathogen-Related Receptors but Dependent on Amino Acid Sequence Variations of IAV NS1

W. Nacken, S. Pleschka, T. Wolff, 2014, Journal of Virology.

D, L-lysine acetylsalicylate + glycine Impairs Coronavirus Replication

Christin Müller, S. Pleschka, J. Ziebuhr, 2016 .

, AP-1 Transcription Factors Activation of Jun N-Terminal Kinase and The Influenza A Virus NS 1 Protein Inhibits

S. Pleschka, A. García-Sastre, T. Wolff, 2002 .

The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo

Christin Müller, S. Pleschka, J. Ziebuhr, 2020, bioRxiv.

NS Reassortment of an H7-Type Highly Pathogenic Avian Influenza Virus Affects Its Propagation by Altering the Regulation of Viral RNA Production and Antiviral Host Response

Nicole C. Robb, S. Pleschka, T. Wolff, 2010, Journal of Virology.

The Role of Hemagglutinin and Neuraminidase in Influenza Virus Pathogenicity

H. Klenk, S. Pleschka, T. Wolff, 2002 .

Hemagglutinin and neuraminidase as determinants of influenza virus pathogenicity

H. Klenk, S. Pleschka, T. Wolff, 2001 .

Phosphorylation of Influenza A Virus Matrix Protein 1 at Threonine 108 Controls Its Multimerization State and Functional Association with the STRIPAK Complex

U. Linne, S. Pleschka, Mahmoud M. Shehata, 2023, mBio.

Correction: Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia

W. Seeger, A. Gruber, S. Pleschka, 2016, PLoS pathogens.

Origin of the European avian-like swine influenza viruses.

M. Platzer, S. Pleschka, M. Groth, 2014, The Journal of general virology.

The genome of an influenza virus from a pilot whale: relation to influenza viruses of gulls and marine mammals.

M. Platzer, S. Pleschka, M. Groth, 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Improved dual promotor-driven reverse genetics system for influenza viruses.

S. Pleschka, J. Ziebuhr, A. Mostafa, 2013, Journal of virological methods.

Efficient Generation of Recombinant Influenza A Viruses Employing a New Approach to Overcome the Genetic Instability of HA Segments

S. Pleschka, H. Petersen, S. Rautenschlein, 2015, PloS one.

Introduction and enzootic of A/H5N1 in Egypt: Virus evolution, pathogenicity and vaccine efficacy ten years on.

M. Beer, S. Pleschka, T. Harder, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

The NS Segment of an H5N1 Highly Pathogenic Avian Influenza Virus (HPAIV) Is Sufficient To Alter Replication Efficiency, Cell Tropism, and Host Range of an H7N1 HPAIV

S. Pleschka, T. Wolff, Kangzheng Yu, 2009, Journal of Virology.

Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity

Christin Müller, S. Pleschka, J. Ziebuhr, 2022, Viruses.

Bacterial ribonuclease binase exerts an intra-cellular anti-viral mode of action targeting viral RNAs in influenza a virus-infected MDCK-II cells

Christin Müller, S. Pleschka, A. Mostafa, 2018, Virology Journal.

Ribonuclease from Bacillus Acts as an Antiviral Agent against Negative- and Positive-Sense Single Stranded Human Respiratory RNA Viruses

Christin Müller, S. Pleschka, Y. Romanova, 2017, BioMed research international.

Identification of specific residues in avian influenza A virus NS1 that enhance viral replication and pathogenicity in mammalian systems.

K. Schughart, S. Pleschka, J. Ziebuhr, 2016, The Journal of general virology.

Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial

S. Pleschka, P. Fisher, P. Klein, 2015, Current therapeutic research, clinical and experimental.

Ancestral sequence reconstruction pinpoints adaptations that enable avian influenza virus transmission in pigs

Gavin J. D. Smith, R. Webster, R. Webby, 2021, Nature microbiology.

Assessing compatibility and viral fitness between poultry-adapted H9N2 and wild bird-derived neuraminidases

S. Pleschka, Anishia Wasberg, Å. Lundkvist, 2023, Scientific Reports.

Post-translational folding of the influenza C virus glycoprotein HEF: defective processing in cells expressing the cloned gene.

H. Klenk, S. Pleschka, M. Veit, 1994, The Journal of general virology.

NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner

S. Pleschka, Mahmoud M. Shehata, F. Pessler, 2023, bioRxiv.

Influenza H3N2 Vaccines: Recent Challenges.

S. Pleschka, A. Mostafa, 2017, Trends in Microbiology.

Improved in vitro Efficacy of Baloxavir Marboxil Against Influenza A Virus Infection by Combination Treatment With the MEK Inhibitor ATR-002

S. Pleschka, Mahmoud M. Shehata, O. Planz, 2021, Frontiers in Microbiology.

The catalytic triad of the influenza C virus glycoprotein HEF esterase: characterization by site-directed mutagenesis and functional analysis.

H. Klenk, S. Pleschka, G. Herrler, 1995, The Journal of general virology.

Influenza A Virus Infection Induces Apical Redistribution of Na+, K+-ATPase in Lung Epithelial Cells In Vitro and In Vivo.

J. Sznajder, M. Hardt, S. Pleschka, 2019, American journal of respiratory cell and molecular biology.

Broad Antiviral Effects of Echinacea purpurea against SARS-CoV-2 Variants of Concern and Potential Mechanism of Action

E. Pariani, S. Pleschka, Mahmoud M. Shehata, 2021, bioRxiv.

The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.

S. Pleschka, J. Ziebuhr, A. Mostafa, 2016, The Journal of general virology.

Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection

K. Schughart, R. Geffers, S. Pleschka, 2022, PLoS pathogens.

Adhesion Molecules Virus Infection: Impact of Chemokines and Transepithelial Migration upon Influenza Alveolar Epithelial Cells Direct Monocyte

W. Seeger, S. Pleschka, M. Mack, 2006 .

Circulation of classical swine influenza virus in Europe between the wars?

M. Platzer, S. Pleschka, C. Scholtissek, 2013, Archives of Virology.

NS Reassortment of an H7-Type Highly Pathogenic Avian Influenza Virus Affects Its Propagation by Altering the Regulation of Viral RNA Production and Antiviral Host Response

Nicole C. Robb, S. Pleschka, T. Wolff, 2010, Journal of Virology.

Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury

S. Pleschka, T. Wolff, S. Ludwig, 2012, Journal of leukocyte biology.

Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virus-infected patients

S. Pleschka, Benjamin Koch, P. Baer, 2024, Frontiers in cellular and infection microbiology.